skip to Main Content
A. COVID 19 Detection Test related Important EUA (Emergency Use Authorization) documents:

A1. Bangladesh EUA no: IMP-049 dated: 14.11.2021 issued by DGDA in-favor of GIS Mapping Bangladesh (GISMBD™) for MobileDetect MD-Bio BCC19, Country of Origin: USA, Manufactured by: MobileDetect Bio Inc., USA

A2. USA EUA No: FDA 201215 dated: 06.17.2021issued by: The United States Food and Drug Administration in-favor of MobileDetect Bio Inc., USA.

A3. United Arab Emirates (UAE) EUA (Approval) Ref no: Ref: DOH/RIC/2021/1094 Dated: 26.08.2021, issued by Department of Health (DoH) of The Emirates,  in-favor of Smart Health Tec, Dubai, UAE,  for MobileDetect MD-Bio BCC19, Country of Origin: USA, Manufactured by: MobileDetect Bio Inc., USA.

B. COVID 19 Detection Test related Other Important documents:

B1. USA Manufacturer MobileDetect Bio Inc.’s confirmation that- their manufactured Rapid PCR (RT-LAMP) BCC19 can detect all variants including Omicron, Lambda, Eta, Lota, Kappa, Zeta, Alpha, Beta, Delta, Gamma & etc. by Test of 30 min, with 98.7% to100% efficiency, as the targeted detection is specificity SARS-COV-2

B2: Table-1 & 2 specifying RT-LAMP vs rt-PCR vs NP Antigen tests/technologies to detect SARS-CoV-2 (COVID-19) Characteristics, Advantages, Disadvantages and Possible Indications of Different Direct Tests. As mentioned in “Dove Press journal” Article “Current Status of Laboratory Diagnosis for: A Narrative Review”, published on Dt: 30-Sep-2021. Mentioning RT-LAMP has faster Turn-over and same Sensitivity & Specificity as of rt-PCR test.

B2: RT-LAMP has faster Turn-over and same Sensitivity & Specificity as of rt-PCR test. Mentioned in “Dove Press journal” Article “Current Status of Laboratory Diagnosis for: A Narrative Review”, published on Dt: 30-Sep-2021. Table-1 & 2 specifying RT-LAMP vs rt-PCR vs NP Antigen tests/technologies to detect SARS-CoV-2 (COVID-19) Characteristics, Advantages, Disadvantages and Possible Indications of Different Direct Tests.

Back To Top